Clinical Trials Logo
  1. Home
  2. Migraine
  3. NCT03872050
  4. Details
NCT03872050 Clinical Trial

Deep Phenotyping of Rosacea and Migraine

Migraine Clinical Trial

Official title:
Deep Phenotyping of Rosacea and Migraine

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03872050
Other study ID # RosMigInterview
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 14, 2018
Est. completion date October 29, 2019

Study information
Verified date August 2020
Source Danish Headache Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to deep phenotype patients with rosacea and migraine

Description:

Rosacea and migraine are common disorders that overlap in epidemiology, symptoms, trigger factors, and distribution in the trigeminal area. Recent studies establish a connection between the two disorders, which needs to be investigated.

The purpose of this study is investigate the link between the two disorders by deep phenotyping through semi-structured interviews.

Recruitment information / eligibility
Status Completed
Enrollment 613
Est. completion date October 29, 2019
Est. primary completion date October 29, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- diagnosis with either rosacea and/or migraine

Exclusion Criteria:

- does not want to participate

- cannot co-operate to investigation

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• No intervention apart from tests, including interview
No interventions

Locations
Country Name City State
Denmark Danish Headache Center Glostrup Zealand

Sponsors (1)
Lead Sponsor Collaborator
Danish Headache Center

Country where clinical trial is conducted

Denmark, 

Outcome
Type Measure Description Time frame Safety issue
Primary Prevalence of migraine in rosacea cohort Prevalence of patients in rosacea cohort who fulfill diagnostic criteria for migraine 60 minutes
Primary Prevalence of rosacea in migraine cohort Prevalence of rosacea in migraine cohort Prevalence of patients in migraine cohort who fulfill diagnostic criteria for rosacea 60 minutes
Secondary Prevalence of migraine subtypes in rosacea cohort Prevalence of patients in rosacea cohort who fulfill diagnostic criteria for subtypes of migraine according to international headache society classification 60 minutes
Secondary Prevalence of rosacea subtypes in migraine cohort Prevalence of patients in migraine cohort who fulfill diagnostic criteria for subtypes of rosacea 60 minutes
See also
  Status Clinical Trial Phase
Completed NCT06192173 - Patent Foramen Ovale Closure in Migraine
Completed NCT05525611 - Cabergoline as a Preventive Treatment for Chronic Migraine N/A
Recruiting NCT03832998 - Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine Phase 3
Enrolling by invitation NCT04196933 - Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma N/A
Not yet recruiting NCT06428838 - Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context Phase 3
Completed NCT06304675 - Manageable Environmental Factors in Migraine
Completed NCT04084314 - Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study Phase 4
Recruiting NCT05517200 - Pilot Study for a Machine Learning Test for Migraine
Completed NCT04179474 - Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine Phase 1
Recruiting NCT04603976 - Registry for Migraine - Clinical Core Phase 4
Completed NCT03597529 - CHOCOlate MeLatonin for AdolescenT MigrainE Phase 2
Completed NCT04197349 - Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman Phase 1
Recruiting NCT05891808 - miR-155 Expression in Episodic and Chronic Migraine
Active, not recruiting NCT05064371 - Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan Phase 3
Suspended NCT04069572 - Vibratory Stimulation for the Treatment of Chronic Pain N/A
Not yet recruiting NCT04859374 - Chronic Pain and Conditioned Pain Modulation After on Line-behavioral Approach N/A
Not yet recruiting NCT03083860 - Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions. N/A
Completed NCT02905227 - A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder Phase 1
Enrolling by invitation NCT02532023 - The Combined Effects of omega3 Fatty Acids and Curcumin Supplementation on Inflammatory and Endothelial Factors in Migraine Patients Phase 4
Completed NCT02108678 - One-Day Intervention for Depression and Impairment in Migraine Patients N/A